ConductScience.org, home

Trial · NCT03181503

Adverse events48

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

TypeEventOrgan systemGroupAffectedAt riskEvents
otherAbdominal PainGastrointestinal disordersPlacebo036
otherAbdominal PainGastrointestinal disordersNemolizumab 0.5 mg/kg234
otherDiarrhoeaGastrointestinal disordersPlacebo036
otherDiarrhoeaGastrointestinal disordersNemolizumab 0.5 mg/kg234
otherArthralgiaMusculoskeletal and connective tissue disordersPlacebo236
otherArthralgiaMusculoskeletal and connective tissue disordersNemolizumab 0.5 mg/kg134
otherCoughRespiratory, thoracic and mediastinal disordersPlacebo236
otherCoughRespiratory, thoracic and mediastinal disordersNemolizumab 0.5 mg/kg034
otherLymphadenopathyBlood and lymphatic system disordersPlacebo036
otherLymphadenopathyBlood and lymphatic system disordersNemolizumab 0.5 mg/kg234
otherIncreased AppetiteMetabolism and nutrition disordersPlacebo036
otherIncreased AppetiteMetabolism and nutrition disordersNemolizumab 0.5 mg/kg234
seriousNeurodermatitisSkin and subcutaneous tissue disordersPlacebo336
seriousNeurodermatitisSkin and subcutaneous tissue disordersNemolizumab 0.5 mg/kg034
seriousDermatitis PsoriasiformSkin and subcutaneous tissue disordersPlacebo036
seriousDermatitis PsoriasiformSkin and subcutaneous tissue disordersNemolizumab 0.5 mg/kg134
seriousEczema NummularSkin and subcutaneous tissue disordersPlacebo036
seriousEczema NummularSkin and subcutaneous tissue disordersNemolizumab 0.5 mg/kg134
seriousClavicle FractureInjury, poisoning and procedural complicationsPlacebo036
seriousClavicle FractureInjury, poisoning and procedural complicationsNemolizumab 0.5 mg/kg134

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03181503/events?page=2